Types of Nicotine: Free-Base, Salt, and Synthetic

Nicotine is not a single, uniform substance. It exists in several distinct chemical forms, comes from different sources, and reaches the body through delivery systems that dramatically alter how fast and how intensely it acts. The two most consequential distinctions are between free-base and salt (protonated) nicotine, and between tobacco-derived and synthetic nicotine. But those are just the starting points: minor alkaloids related to nicotine, emerging lab-designed analogs, and the way the body’s own enzymes process the molecule all add layers that matter for anyone trying to understand what they’re actually inhaling, chewing, or absorbing through their skin.

Free-Base Versus Salt Nicotine

Every nicotine molecule can exist in two main chemical states: free-base or protonated (salt). The difference comes down to pH. In a more alkaline environment, nicotine stays in its free-base form. Add an acid and the molecule picks up a hydrogen ion, becoming a protonated nicotine salt. This isn’t just a chemistry curiosity; it changes how nicotine feels in the throat and how efficiently it enters the bloodstream.

Free-base nicotine is harsher. At higher concentrations it produces a strong throat hit that many users find unpleasant, which is one reason older e-cigarettes tended to use relatively low nicotine levels. Nicotine salts, formed by combining nicotine with an organic acid like benzoic acid or lactic acid, lower the pH of the aerosol. That shift reduces harshness and increases smoothness, sweetness, and overall appeal compared to free-base nicotine at the same concentration.¹ The practical result is that salt-based products can pack much higher nicotine concentrations into a puff without making you cough.

This matters for how quickly nicotine reaches the brain. In a crossover study comparing salt and free-base e-cigarette formulations, a 40 mg/mL nicotine salt liquid produced a median peak blood nicotine level roughly four times higher than a 20 mg/mL free-base liquid, and about twice as high as a 20 mg/mL salt liquid. All three formulations hit their peak within about two to two and a half minutes after the last puff.² The speed is comparable across forms, but the amount of nicotine delivered is not. Acid additives that shift nicotine toward its salt form don’t just improve taste; they also increase blood nicotine yield.³

Traditional cigarettes exploit this same chemistry. Tobacco companies have long manipulated the proportion of free-base to protonated nicotine through additives like ammonia, which raises pH and increases the free-base fraction. The correlation between pH and nicotine partitioning is strong enough that measuring pH can serve as a quick proxy for how much nicotine is in its free-base state.⁴ In cigarettes, more free-base nicotine means faster absorption through the lungs. In modern vaping products, the strategy has flipped: salt forms dominate because they allow high doses without the burning sensation.

Tobacco-Derived Versus Synthetic Nicotine

Until recently, virtually all commercial nicotine was extracted from tobacco leaves. Synthetic nicotine, made in a lab without any tobacco plant material, entered the market partly as a regulatory workaround: in the United States, the FDA’s authority over tobacco products initially applied only to products derived from tobacco, so some manufacturers labeled their products “tobacco-free nicotine” to sidestep oversight. That loophole was closed in 2022 when Congress extended FDA authority to cover all nicotine products regardless of source.

Chemically, synthetic and tobacco-extracted nicotine are similar but not identical. Both have roughly the same total level of impurities, about 0.1%. However, synthetic nicotine tends to lack certain byproducts found in tobacco-extracted nicotine, such as cotinine, nornicotine, and nicotine-N-oxide.⁵ Whether those differences have any meaningful health consequences remains unclear, and the practical effect on the user is negligible at the concentrations involved.

The Mirror-Image Problem

Nicotine exists in two mirror-image forms, called enantiomers: (S)-nicotine and (R)-nicotine. Tobacco plants produce almost exclusively the (S) form, typically 99% or more. The (S) enantiomer is the one that binds strongly to nicotinic receptors in the brain and drives the familiar effects of nicotine use.

Synthetic nicotine, depending on the manufacturing process, can come out as a roughly equal mix of both forms, known as a racemic mixture. Researchers tested Puff Bar e-cigarettes marketed as containing “tobacco-free nicotine” and confirmed they did in fact contain both (R) and (S) isomers, though with slightly more of the (S) form.⁶ Older Puff Bars, before the reformulation, contained only (S)-nicotine, consistent with tobacco-derived sourcing. Some synthetic nicotine producers have since developed methods to achieve high enantiomeric purity, producing nearly pure (S)-nicotine synthetically.⁷

The (R) form has weaker pharmacological activity, so a racemic product with the same total nicotine concentration as a tobacco-derived one would deliver less of the “active” ingredient per milligram. For consumers, this means a racemic synthetic product might feel slightly less potent puff-for-puff than an equivalent tobacco-derived or enantiomerically pure synthetic product. In practice, manufacturers can simply adjust the concentration to compensate.

Nicotine in Replacement Therapies

Nicotine replacement therapy (NRT) products use nicotine in forms specifically engineered for slow, steady delivery rather than the sharp spikes that make cigarettes so reinforcing. The main categories are patches, gums, lozenges, nasal sprays, and inhalers, and each handles nicotine differently.

Patches deliver nicotine through the skin at a controlled rate. A comparison of the three main patch systems available found meaningful differences in how much nicotine they actually deliver. The 21 mg, 24-hour patches produced higher total absorption and higher peak blood levels than the 15 mg, 16-hour patch, and even between the two 24-hour patches, one brand delivered significantly more nicotine than the other despite carrying the same labeled dose.⁸ The adhesive layers, rate-controlling membranes, and reservoir designs all influence the delivery profile.⁹ This is why “21 mg patch” doesn’t mean the same experience across all brands.

Nicotine gum uses a different trick. The nicotine is bound to an ion-exchange resin, and chewing releases it gradually into the saliva, where it’s absorbed through the lining of the mouth. The strength of the resin bond matters: a stronger resin slows the release.¹⁰ This is intentional. Oral NRT products absorb much more slowly than inhaled nicotine, which is exactly why they have substantially lower abuse potential than cigarettes or vapes.¹¹ The slow ramp-up tamps down cravings without producing the rapid peak that reinforces addiction.

Why Delivery Speed Shapes Addiction Risk

The addictiveness of nicotine is not just about dose. It’s heavily influenced by how fast the dose reaches the brain. Cigarettes deliver nicotine to the brain in roughly ten seconds. E-cigarettes using nicotine salts get close to that speed, though they typically don’t hit quite as high a peak as combustible cigarettes in the same timeframe. Nicotine gum and patches, by contrast, take many minutes or even hours to approach their peak blood levels.

Research comparing vaping devices to cigarettes and gum found that inhaled nicotine products suppressed the urge to smoke more effectively than gum, which tracks with the faster absorption through the lungs. But cigarettes still produced faster peak times than the vaping devices tested, partly because a cigarette is smoked in five to seven minutes while the vaping sessions in the study lasted ten minutes.¹² The general principle holds across the literature: slower delivery means lower abuse potential, and the form of nicotine and the route of administration together determine that speed.¹³

Minor Tobacco Alkaloids

Nicotine accounts for about 95% of the alkaloid content in tobacco, but it is not alone.¹⁴ The remaining 5% includes nornicotine, anatabine, and anabasine, all structurally related to nicotine. These minor alkaloids are often overlooked, but they interact with nicotine receptors in their own ways.

In rodent studies, all three minor alkaloids could substitute for nicotine’s subjective effects. Anabasine reduced nicotine withdrawal symptoms, and all three reduced how much nicotine rats chose to self-administer. But only nornicotine was self-administered on its own, suggesting it carries some independent abuse potential. Anatabine and anabasine did not function as stand-alone rewards.¹⁵ These findings raise an interesting possibility: minor alkaloids might partially satisfy nicotine cravings without being as addictive as nicotine itself. Whether that translates to therapeutic potential in humans is an open question.

Emerging Nicotine Analogs

A newer category is generating concern among regulators: synthetic nicotine analogs that are structurally similar to nicotine but just different enough to fall outside existing regulatory definitions. The most prominent example is 6-methyl nicotine (6-MN), which has begun appearing in vaping products and nicotine pouches. It differs from regular nicotine by a single methyl group added to the pyridine ring. That small structural change increases the molecule’s affinity for the brain’s main nicotinic receptors and may make it more addictive than conventional nicotine.¹⁶

The safety data on 6-MN and other analogs is extremely thin. These compounds have not been through the kind of testing that even nicotine itself has undergone, and the regulatory frameworks in most countries are still catching up. For consumers, the practical message is straightforward: these products are poorly understood, and “nicotine-like” does not mean “nicotine-equivalent” in terms of risk.

Toxicology Differences Between Nicotine Forms

Choosing between free-base and salt nicotine isn’t just a question of smoothness and speed. The acids used to form nicotine salts are not inert passengers in the aerosol. In cell studies, benzoic acid-based nicotine salts triggered more inflammation and oxidative stress than free-base nicotine.¹⁷ Salicylic acid-based salts were less damaging on the oxidative stress front, suggesting the choice of acid matters.

The acid also affects what harmful byproducts form when the liquid is heated. E-liquids made with polycarboxylic acids like citric acid, malic acid, or oxalic acid produced higher levels of acrolein, a toxic aldehyde, compared to those using monocarboxylic acids like benzoic or lactic acid.¹⁸ So “nicotine salt” is not a single thing from a toxicology standpoint. Which acid is in the formula, and what that acid does at vaping temperatures, varies considerably.

How Your Body Processes Nicotine

Regardless of which form enters the body, nicotine is metabolized along the same primary pathway. The liver enzyme CYP2A6 converts nicotine into cotinine in a two-step process. This is the dominant route and accounts for the bulk of nicotine clearance.¹⁹ Cotinine sticks around in the blood much longer than nicotine itself, which is why it is the standard biomarker for nicotine exposure in clinical tests.

Not everyone processes nicotine at the same rate. Genetic variation in the CYP2A6 gene creates a wide range of metabolic speeds. Researchers classify people as normal metabolizers (over 75% enzyme activity), intermediate (roughly 50–75%), slow (25–50%), or poor (under 25%).²⁰ If you metabolize nicotine slowly, each dose lingers longer, which tends to mean you smoke fewer cigarettes per day but may also mean certain cessation strategies work differently for you. Fast metabolizers, on the other hand, clear nicotine quickly and tend to smoke more to maintain the level their brain expects. This genetic variation is one reason two people can use the exact same nicotine product and have very different experiences.

Menthol and the Sensory Side

Menthol deserves mention not because it’s a type of nicotine, but because it fundamentally changes how nicotine feels and behaves. At high concentrations, menthol reduced the perceived harshness of high-nicotine e-cigarette solutions while slightly increasing liking, independent of nicotine level.²¹ The cooling sensation masks the irritation that might otherwise limit how much nicotine a user is willing to inhale.

At the receptor level, menthol does something more interesting. It promotes the desensitization of certain nicotinic receptors, meaning the receptors become temporarily less responsive to nicotine after being exposed to menthol alongside nicotine or acetylcholine.²² This creates a paradox: menthol makes nicotine easier to inhale while also blunting some of the receptor activity that nicotine depends on. The net effect, in population-level data, is that menthol cigarette smokers often find it harder to quit than non-menthol smokers, possibly because the smoother experience encourages heavier use patterns that more than compensate for any dampening at the receptor level.

Nicotine in Everyday Foods

Nicotine is not exclusively a product of tobacco. It occurs naturally in small amounts across the nightshade family of plants, which includes tomatoes, eggplants, potatoes, and peppers. The concentrations are tiny compared to tobacco: fresh nightshade fruits contain roughly 2 to 7 micrograms per kilogram, and the average daily dietary intake from food has been estimated at about 1.4 micrograms, with the 95th percentile around 2.25 micrograms.²³ For perspective, a single cigarette delivers roughly 1,000 to 2,000 micrograms of nicotine to the bloodstream. You would need to eat an implausible amount of eggplant to come close to what one puff of a vape delivers. The nicotine in food is pharmacologically irrelevant, but it does occasionally show up in conversations about whether dietary nicotine could trigger a positive drug test. It can’t, at normal eating levels.

Tomatoes are an interesting case within this group because their nicotine content drops as the fruit ripens. A green tomato has more nicotine than a red one. This is consistent with nicotine’s role in the plant as an insect deterrent: the plant produces more of it when the fruit is immature and doesn’t “want” to be eaten yet. Once the seeds are ready for dispersal, nicotine production tapers off.